{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:25:31Z","timestamp":1790814331324,"version":"4.1.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T00:00:00Z","timestamp":1644278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T00:00:00Z","timestamp":1644278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Vice chancellor for Research, Kashan University of Medical Sciences, Kashan, Iran."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Amino Acids"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s00726-022-03134-8","type":"journal-article","created":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T11:04:54Z","timestamp":1644318294000},"page":"433-440","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Effects of N-acetylcysteine supplementation on disease activity, oxidative stress, and inflammatory and metabolic parameters in rheumatoid arthritis patients: a randomized double-blind placebo-controlled trial"],"prefix":"10.1007","volume":"54","author":[{"given":"Kamal","family":"Esalatmanesh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Jamali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roozbeh","family":"Esalatmanesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Soleimani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Khabbazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0176-5438","authenticated-orcid":false,"given":"Aida","family":"Malek Mahdavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,8]]},"reference":[{"key":"3134_CR1","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.arcmed.2015.08.006","volume":"46","author":"H Abdollahzad","year":"2015","unstructured":"Abdollahzad H, Aghdashi MA, AsghariJafarabadi M, Alipour B (2015) Effects of coenzyme Q10 supplementation on inflammatory cytokines (TNF-\u03b1, IL-6) and oxidative stress in rheumatoid arthritis patients: a randomized controlled trial. Arch Med Res 46:527\u2013533","journal-title":"Arch Med Res"},{"key":"3134_CR2","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO et al (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62:2569\u20132581","journal-title":"Arthritis Rheum"},{"key":"3134_CR3","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.rbr.2014.07.003","volume":"54","author":"AM Ali","year":"2014","unstructured":"Ali AM, Habeeb RA, El-Azizi NO, Khattab DA, Abo-Shady RA, Elkabarity RH (2014) N\u00edveis de \u00f3xido n\u00edtrico mais elevados est\u00e3o associados \u00e0 atividade da doen\u00e7a em pacientes eg\u00edpcios com artrite reumatoide [Higher nitric oxide levels are associated with disease activity in Egyptian rheumatoid arthritis patients]. Rev Bras Reumatol 54:446\u2013451","journal-title":"Rev Bras Reumatol"},{"key":"3134_CR4","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0735-1097(00)01093-7","volume":"37","author":"NP Andrews","year":"2001","unstructured":"Andrews NP, Prasad A, Quyyumi AA (2001) N-Acetylcysteine improves coronary and peripheral vascular function. J Am Coll Cardiol 37:117\u2013123","journal-title":"J Am Coll Cardiol"},{"key":"3134_CR5","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/0891-5849(89)90066-X","volume":"6","author":"OI Aruoma","year":"1989","unstructured":"Aruoma OI, Halliwell B, Hoey BM, Butler J (1989) The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic Biol Med 6:593\u2013597","journal-title":"Free Radic Biol Med"},{"key":"3134_CR6","doi-asserted-by":"publisher","first-page":"132","DOI":"10.2174\/1574887113666180307151937","volume":"13","author":"M Batooei","year":"2018","unstructured":"Batooei M, Tahamoli-Roudsari A, Basiri Z, Yasrebifar F, Shahdoust M, Eshraghi A et al (2018) Evaluating the effect of oral N-acetylcysteine as an adjuvant treatment on clinical outcomes of patients with rheumatoid arthritis: a randomized, double blind clinical trial. Rev Recent Clin Trials 13:132\u2013138","journal-title":"Rev Recent Clin Trials"},{"key":"3134_CR7","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3899\/jrheum.190008","volume":"47","author":"K Bechman","year":"2020","unstructured":"Bechman K, Yates M, Norton S, Cope AP, Galloway JB (2020) Placebo response in rheumatoid arthritis clinical trials. J Rheumatol 47:28\u201334","journal-title":"J Rheumatol"},{"key":"3134_CR8","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1093\/aje\/kwf205","volume":"157","author":"JR Cerhan","year":"2003","unstructured":"Cerhan JR, Saag KG, Merlino LA, Mikuls TR, Criswell LA (2003) Antioxidant micronutrients and risk of rheumatoid arthritis in a cohort of older women. Am J Epidemiol 157:345\u2013354","journal-title":"Am J Epidemiol"},{"key":"3134_CR9","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1872-034X.2007.00215.x","volume":"38","author":"CP de Oliveira","year":"2008","unstructured":"de Oliveira CP, Stefano JT, de Siqueira ER, Silva LS, de Campos Mazo DF, Lima VM et al (2008) Combination of N-acetylcysteine and metformin improves histological steatosis and fibrosis in patients with non-alcoholic steatohepatitis. Hepatol Res 38:159\u2013165","journal-title":"Hepatol Res"},{"key":"3134_CR10","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1056\/NEJMoa042976","volume":"353","author":"M Demedts","year":"2005","unstructured":"Demedts M, Behr J, Buhl R, Costabel U, Dekhuijzen R, Jansen HM, IFIGENIA Study Group et al (2005) High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 353:2229\u20132242","journal-title":"N Engl J Med"},{"key":"3134_CR11","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1136\/ard.56.11.649","volume":"56","author":"SE Edmonds","year":"1997","unstructured":"Edmonds SE, Winyard PG, Guo R, Kidd B, Merry P, Langrish-Smith A et al (1997) Putative analgesic activity of repeated oral doses of vitamin E in the treatment of rheumatoid arthritis. Results of a prospective placebo controlled double blind trial. Ann Rheumat Dis 56:649\u2013655","journal-title":"Ann Rheumat Dis"},{"key":"3134_CR12","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s00296-009-1206-y","volume":"30","author":"P Efthimiou","year":"2009","unstructured":"Efthimiou P, Kukar M (2009) Complementary and alternative medicine use in rheumatoid arthritis: proposed mechanism of action and efficacy of commonly used modalities. Rheumatol Int 30:571\u2013586","journal-title":"Rheumatol Int"},{"key":"3134_CR13","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/1529-0131(200201)46:1<175::AID-ART10015>3.0.CO;2-H","volume":"46","author":"P Gergely Jr","year":"2002","unstructured":"Gergely P Jr, Grossman C, Niland B, Puskas F, Neupane H, Allam F et al (2002) Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus. Arthritis Rheum 46:175\u2013190","journal-title":"Arthritis Rheum"},{"key":"3134_CR14","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/1043-4666(91)90015-6","volume":"3","author":"P Ghezzi","year":"1991","unstructured":"Ghezzi P, Dinarello CA, Bianchi M, Rosandich ME, Repine JE, White CW (1991) Hypoxia increases production of interleukin-1 and tumor necrosis factor by human mononuclear cells. Cytokine 3:189\u2013194","journal-title":"Cytokine"},{"key":"3134_CR15","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.freeradbiomed.2004.09.025","volume":"38","author":"L Grinberg","year":"2005","unstructured":"Grinberg L, Fibach E, Amer J, Atlas D (2005) N-Acetylcysteine amide, a novel cell-permeating thiol, restores cellular glutathione and protects human red blood cells from oxidative stress. Free Radic Biol Med 38:136\u2013145","journal-title":"Free Radic Biol Med"},{"key":"3134_CR16","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.3748\/wjg.14.2851","volume":"14","author":"LG Guijarro","year":"2008","unstructured":"Guijarro LG, Mate J, Gisbert JP, Perez-Calle JL, Marin-Jimenez I, Arriaza E et al (2008) N-Acetyl-l-cysteine combined with mesalamine in the treatment of ulcerative colitis: randomized, placebo-controlled pilot study. World J Gastroenterol 14:2851\u20132857","journal-title":"World J Gastroenterol"},{"key":"3134_CR17","first-page":"7","volume":"45","author":"K Hadjigogos","year":"2003","unstructured":"Hadjigogos K (2003) The role of free radicals in the pathogenesis of rheumatoid arthritis. Panminerva Med 45:7\u201313","journal-title":"Panminerva Med"},{"key":"3134_CR18","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2133\/dmpk.19.297","volume":"19","author":"D Harada","year":"2004","unstructured":"Harada D, Anraku M, Fukuda H, Naito S, Harada K, Suenaga A et al (2004) Kinetic studies of covalent binding between N-acetyl-l-cysteine and human serum albumin through a mixed-disulfide using an N-methylpyridinium polymerbased column. Drug Metab Pharmacokinet 19:297\u2013302","journal-title":"Drug Metab Pharmacokinet"},{"key":"3134_CR19","doi-asserted-by":"publisher","first-page":"246","DOI":"10.2174\/1573403X14666180926100811","volume":"15","author":"G Hashemi","year":"2019","unstructured":"Hashemi G, Mirjalili M, Basiri Z, Tahamoli-Roudsari A, Kheiripour N, Shahdoust M et al (2019) A pilot study to evaluate the effects of oral N-acetyl cysteine on inflammatory and oxidative stress biomarkers in rheumatoid arthritis. Curr Rheumatol Rev 15:246\u2013253","journal-title":"Curr Rheumatol Rev"},{"key":"3134_CR20","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/jat.736","volume":"21","author":"MQ Hassan","year":"2001","unstructured":"Hassan MQ, Hadi RA, Al-Rawi ZS, Padron VA, Stohs SJ (2001) The glutathione defense system in the pathogenesis of rheumatoid arthritis. J Appl Toxicol 21:69\u201373","journal-title":"J Appl Toxicol"},{"key":"3134_CR21","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2165\/00003088-199120020-00004","volume":"20","author":"MR Holdiness","year":"1991","unstructured":"Holdiness MR (1991) Clinical pharmacokinetics of N-acetylcysteine. Clin Pharmacokinet 20:123\u2013134","journal-title":"Clin Pharmacokinet"},{"key":"3134_CR22","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.cccn.2003.08.011","volume":"338","author":"S Jaswal","year":"2003","unstructured":"Jaswal S, Mehta HC, Sood AK, Kaur J (2003) Antioxidant status in rheumatoid arthritis and role of antioxidant therapy. Clin Chim Acta 338:123\u2013129","journal-title":"Clin Chim Acta"},{"key":"3134_CR23","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3109\/09513590.2015.1115974","volume":"32","author":"F Javanmanesh","year":"2016","unstructured":"Javanmanesh F, Kashanian M, Rahimi M, Sheikhansari N (2016) A comparison between the effects of metformin and N-acetyl cysteine (NAC) on some metabolic and endocrine characteristics of women with polycystic ovary syndrome. Gynecol Endocrinol 32:285\u2013289","journal-title":"Gynecol Endocrinol"},{"key":"3134_CR24","first-page":"363","volume":"4","author":"H Jonsson","year":"1986","unstructured":"Jonsson H, Wollheim FA, Svensson B (1986) No effect of acetylcystein on refractory rheumatoid arthritis. Clin Exp Rheumatol 4:363\u2013364","journal-title":"Clin Exp Rheumatol"},{"key":"3134_CR25","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/cbf.1055","volume":"22","author":"A Kamanli","year":"2004","unstructured":"Kamanli A, Naziro\u011flu M, Aydilek N, Hacievliyagil C (2004) Plasma lipid peroxidation and antioxidant levels in patients with rheumatoid arthritis. Cell Biochem Funct 22:53\u201357","journal-title":"Cell Biochem Funct"},{"key":"3134_CR26","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3904\/kjim.2016.329","volume":"34","author":"HR Kim","year":"2019","unstructured":"Kim HR, Kim KW, Kim BM, Lee KA, Lee SH (2019) N-acetyl-l-cysteine controls osteoclastogenesis through regulating Th17 differentiation and RANKL production in rheumatoid arthritis. Korean J Intern Med 34:210\u2013219","journal-title":"Korean J Intern Med"},{"key":"3134_CR27","doi-asserted-by":"publisher","first-page":"35","DOI":"10.4137\/CMAMD.S5558","volume":"6","author":"P Kumar","year":"2013","unstructured":"Kumar P, Banik S (2013) Pharmacotherapy options in rheumatoid arthritis. Clin Med Insights Arthritis Musculoskelet Disord 6:35\u201343","journal-title":"Clin Med Insights Arthritis Musculoskelet Disord"},{"key":"3134_CR28","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1002\/art.34502","volume":"64","author":"ZW Lai","year":"2012","unstructured":"Lai ZW, Hanczko R, Bonilla E, Caza TN, Clair B, Bartos A et al (2012) N-Acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 64:2937\u20132946","journal-title":"Arthritis Rheum"},{"key":"3134_CR29","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/11745-006-5066-x","volume":"41","author":"BF Leeb","year":"2006","unstructured":"Leeb BF, Sautner J, Andel I, Rintelen B (2006) Intravenous application of omega-3 fatty acids in patients with active rheumatoid arthritis. The ORA-1 trial. An open pilot study. Lipids 41:29\u201334","journal-title":"Lipids"},{"key":"3134_CR30","doi-asserted-by":"publisher","first-page":"e0152925","DOI":"10.1371\/journal.pone.0152925","volume":"11","author":"S Mateen","year":"2016","unstructured":"Mateen S, Moin S, Khan AQ, Zafar A, Fatima N (2016) Increased reactive oxygen species formation and oxidative stress in rheumatoid arthritis. PLoS ONE 11:e0152925","journal-title":"PLoS ONE"},{"key":"3134_CR31","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/NEJMra1004965","volume":"365","author":"IB McInnes","year":"2011","unstructured":"McInnes IB, Schett G (2011) The pathogenesis of rheumatoid arthritis. N Engl J Med 365:2205\u20132219","journal-title":"N Engl J Med"},{"key":"3134_CR32","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0003-2697(78)90342-1","volume":"86","author":"M Mihara","year":"1978","unstructured":"Mihara M, Uchiyama M (1978) Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 86:271\u2013278","journal-title":"Anal Biochem"},{"key":"3134_CR33","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1042\/cs0840407","volume":"84","author":"NJ Miller","year":"1993","unstructured":"Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V, Milner A (1993) A novel method for measuring antioxidant capacity and its application for monitoring the antioxidant status in premature neonates. Clin Sci 84:407\u2013412","journal-title":"Clin Sci"},{"key":"3134_CR34","doi-asserted-by":"publisher","first-page":"3367","DOI":"10.1007\/s10067-019-04723-x","volume":"38","author":"SM Nachvak","year":"2019","unstructured":"Nachvak SM, Alipour B, Mahdavi AM, Aghdashi MA, Abdollahzad H, Pasdar Y et al (2019) Effects of coenzyme Q10 supplementation on matrix metalloproteinases and DAS-28 in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled clinical trial. Clin Rheumatol 38:3367\u20133374","journal-title":"Clin Rheumatol"},{"key":"3134_CR35","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ejogrb.2011.07.005","volume":"159","author":"G Oner","year":"2011","unstructured":"Oner G, Muderris II (2011) Clinical, endocrine and metabolic effects of metformin vs N-acetyl-cysteine in women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 159:127\u2013131","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"3134_CR36","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1177\/1947603516675915","volume":"8","author":"M Ozcamdalli","year":"2017","unstructured":"Ozcamdalli M, Misir A, Kizkapan TB, Uzun E, Duygulu F, Yazici C et al (2017) Comparison of intra-articular injection of hyaluronic acid and N-acetyl cysteine in the treatment of knee osteoarthritis: a pilot study. Cartilage 8:384\u2013390","journal-title":"Cartilage"},{"key":"3134_CR37","doi-asserted-by":"publisher","first-page":"2835787","DOI":"10.1155\/2018\/2835787","volume":"2018","author":"Y Pei","year":"2018","unstructured":"Pei Y, Liu H, Yang Y, Yang Y, Jiao Y, Tay FR et al (2018) Biological activities and potential oral applications of N-acetylcysteine: progress and prospects. Oxid Med Cell Longev 2018:2835787","journal-title":"Oxid Med Cell Longev"},{"key":"3134_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/014860719902300101","volume":"23","author":"LR Pena","year":"1999","unstructured":"Pena LR, Hill DB, McClain CJ (1999) Treatment with glutathione precursor decreases cytokine activity. J Parent Enteral Nutr 23:1\u20136","journal-title":"J Parent Enteral Nutr"},{"key":"3134_CR39","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1080\/030097401316909549","volume":"30","author":"A Peretz","year":"2001","unstructured":"Peretz A, Siderova V, N\u00e8ve J (2001) Selenium supplementation in rheumatoid arthritis investigated in a double blind, placebo-controlled trial. Scandinav J Rheumatol 30:208\u2013212","journal-title":"Scandinav J Rheumatol"},{"key":"3134_CR40","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1002\/art.40223","volume":"69","author":"A Perl","year":"2017","unstructured":"Perl A (2017) Review: metabolic control of immune system activation in rheumatic diseases. Arthritis Rheumatol 69:2259\u20132270","journal-title":"Arthritis Rheumatol"},{"key":"3134_CR41","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1089\/met.2020.0017","volume":"18","author":"M Rani","year":"2020","unstructured":"Rani M, Aggarwal R, Vohra K (2020) Effect of N-acetylcysteine on metabolic profile in metabolic syndrome patients. Metab Syndr Relat Disord 18:341\u2013346","journal-title":"Metab Syndr Relat Disord"},{"key":"3134_CR42","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1002\/art.21111","volume":"52","author":"PH Remans","year":"2005","unstructured":"Remans PH, van Oosterhout M, Smeets TJ, Sanders M, Frederiks WM, Reedquist KA et al (2005) Intracellular free radical production in synovial T lymphocytes from patients with rheumatoid arthritis. Arthritis Rheum 52:2003\u20132009","journal-title":"Arthritis Rheum"},{"key":"3134_CR43","unstructured":"Remans P, Zuijderduin W, Levahrt N, Schuitemaker J, Tak PP, Breedveld FC et al (1997) High dose intravenous Nacetyl-L-cysteine (NAC) therapy in rheumatoid arthritis, results from a pilot study. Role of reactive oxygen species in rheumatoid arthritis synovial t lymphocytes"},{"key":"3134_CR44","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0891-5849(00)00288-4","volume":"29","author":"J Renke","year":"2000","unstructured":"Renke J, Popadiuk S, Korzon M, Bugajczyk B, Wozniak M (2000) Protein carbonyl groups\u2019 content as a useful clinical marker of antioxidant barrier impairment in plasma of children with juvenile chronic arthritis. Free Radic Biol Med 29:101\u2013104","journal-title":"Free Radic Biol Med"},{"key":"3134_CR45","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1089\/152308602753625988","volume":"4","author":"C Rota","year":"2002","unstructured":"Rota C, Bergamini S, Daneri F, Tomasi A, Virgili F, Iannone A (2002) N-Acetylcysteine negatively modulates nitric oxide production in endotoxin-treated rats through inhibition of NF-kappaB activation. Antioxid Redox Signal 4:221\u2013226","journal-title":"Antioxid Redox Signal"},{"key":"3134_CR46","doi-asserted-by":"publisher","first-page":"66","DOI":"10.4103\/1319-2442.124489","volume":"25","author":"F Saddadi","year":"2014","unstructured":"Saddadi F, Alatab S, Pasha F, Ganji MR, Soleimanian T (2014) The effect of treatment with N-acetylcysteine on the serum levels of C-reactive protein and interleukin-6 in patients on hemodialysis. Saudi J Kidney Dis Transpl 25:66\u201372","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"3134_CR47","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1093\/intimm\/8.10.1483","volume":"8","author":"S Sakurada","year":"1996","unstructured":"Sakurada S, Kato T, Okamoto T (1996) Induction of cytokines and ICAM-1 by proinflammatory cytokines in primary rheumatoid synovial fibroblasts and inhibition by N-acetyl-l-cysteine and aspirin. Int Immunol 8:1483\u20131493","journal-title":"Int Immunol"},{"key":"3134_CR48","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1177\/039463200501800420","volume":"18","author":"F Salsano","year":"2005","unstructured":"Salsano F, Letizia C, Proietti M, Rossi C, Proietti AR, Rosato E et al (2005) Significant changes of peripheral perfusion and plasma adrenomedullin levels in N-acetylcysteine long term treatment of patients with sclerodermic Raynauds phenomenon. Int J Immunopathol Pharmacol 18:761\u2013770","journal-title":"Int J Immunopathol Pharmacol"},{"key":"3134_CR49","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.2174\/0929867033456567","volume":"10","author":"F Santangelo","year":"2003","unstructured":"Santangelo F (2003) Intracellular thiol concentration modulating inflammatory response: influence on the regulation of cell functions through cysteine prodrug approach. Curr Med Chem 10:2599\u20132610","journal-title":"Curr Med Chem"},{"key":"3134_CR50","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.clinbiochem.2005.08.003","volume":"38","author":"S Sarban","year":"2005","unstructured":"Sarban S, Kocyigit A, Yazar M, Isikan UE (2005) Plasma total antioxidant capacity, lipid peroxidation, and erythrocyte antioxidant enzyme activities in patients with rheumatoid arthritis and osteoarthritis. Clin Biochem 38:981\u2013986","journal-title":"Clin Biochem"},{"key":"3134_CR51","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1016\/S0735-1097(02)01797-7","volume":"39","author":"J Sochman","year":"2002","unstructured":"Sochman J (2002) N-Acetylcysteine in acute cardiology: 10 years later: what do we know and what would we like to know? J Am Coll Cardiol 39:1422\u20131428","journal-title":"J Am Coll Cardiol"},{"key":"3134_CR52","first-page":"141","volume":"10","author":"K Tewthanom","year":"2011","unstructured":"Tewthanom K, Janwityanujit S, Totemchockchyakarn K, Panomvana D (2011) Pharmacodynamic effect of N-acetylcysteine as adjunctive therapy in mild systemic lupus erythematosus patients. Trop J Pharmaceut Res 10:141\u2013146","journal-title":"Trop J Pharmaceut Res"},{"key":"3134_CR53","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1046\/j.1365-2249.1999.00749.x","volume":"115","author":"F Tsuji","year":"1999","unstructured":"Tsuji F, Miyake Y, Aono H, Kawashima Y, Mita S (1999) Effects of bucillamine and N-acetyl-l-cysteine on cytokine production and collagen-induced arthritis (CIA). Clin Exp Immunol 115:26\u201331","journal-title":"Clin Exp Immunol"},{"key":"3134_CR54","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3390\/nu9040325","volume":"9","author":"M Veselinovic","year":"2017","unstructured":"Veselinovic M, Vasiljevic D, Vucic V, Arsic A, Petrovic S, Tomic-Lucic A et al (2017) Clinical benefits of n-3 PUFA and \u0264-linolenic acid in patients with rheumatoid arthritis. Nutrients 9:325","journal-title":"Nutrients"},{"key":"3134_CR55","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/BF02913075","volume":"21","author":"D Vijayakumar","year":"2006","unstructured":"Vijayakumar D, Suresh K, Manoharan S (2006) Lipid peroxidation and antioxidant status in blood of rheumatoid arthritis patients. Indian J Clin Biochem 21:104\u2013108","journal-title":"Indian J Clin Biochem"},{"key":"3134_CR56","first-page":"253","volume":"61","author":"MT Walters","year":"1986","unstructured":"Walters MT, Rubin CE, Keightley SJ, Ward CD, Cawley MI (1986) A double-blind, cross-over, study of oral N-acetylcysteine in Sj\u00f6gren\u2019s syndrome. Scand J Rheumatol Suppl 61:253\u2013258","journal-title":"Scand J Rheumatol Suppl"},{"key":"3134_CR57","doi-asserted-by":"publisher","first-page":"331ra38","DOI":"10.1126\/scitranslmed.aad7151","volume":"8","author":"Z Yang","year":"2016","unstructured":"Yang Z, Shen Y, Oishi H, Matteson EL, Tian L, Goronzy JJ et al (2016) Restoring oxidant signaling suppresses proarthritogenic T cell effector functions in rheumatoid arthritis. Sci Transl Med. 8:331ra38","journal-title":"Sci Transl Med."}],"container-title":["Amino Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-022-03134-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00726-022-03134-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-022-03134-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T05:06:57Z","timestamp":1700197617000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00726-022-03134-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,8]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["3134"],"URL":"https:\/\/doi.org\/10.1007\/s00726-022-03134-8","relation":{},"ISSN":["0939-4451","1438-2199"],"issn-type":[{"value":"0939-4451","type":"print"},{"value":"1438-2199","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,8]]},"assertion":[{"value":"24 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None was declared.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This research involves human participants. Written informed consent was obtained from all study participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}